Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory <i>Mycobacterium avium</i> Complex Pulmonary Disease

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory <i>Mycobacterium avium</i> Complex Pulmonary Disease

Limited data are available regarding optimal treatment for refractory <i>Mycobacterium avium</i> complex-pulmonary disease (MAC-PD). We evaluated outcomes of inhaled amikacin (AMK) with clofazimine (CFZ) regimens as an add-on salvage therapy for refractory MAC-PD. We retrospectively anal...

Full description

Bibliographic Details
Main Authors: Bo-Guen Kim, Hojoong Kim, O. Jung Kwon, Hee Jae Huh, Nam Yong Lee, Sun-Young Baek, Insuk Sohn, Byung Woo Jhun
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
<i>Mycobacterium avium</i>
refractory
inhalation
amikacin
clofazimine
Online Access:https://www.mdpi.com/2077-0383/9/9/2968

Internet

https://www.mdpi.com/2077-0383/9/9/2968

Similar Items